Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer

Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer

OBJECTIVES: To establish a formula that estimates tumor volume in localized prostate cancer based on serum prostate specific antigen levels. One of the main prognostic variables in localized prostate cancer is tumor volume, which can be precisely defined only after prostate extirpation. The present...

Full description

Bibliographic Details
Main Authors:	Raphael Barroso Kato, Victor Srougi, Fernanda Aburesi Salvadori, Pedro Paulo Marino Rodrigues Ayres, Katia Moreira Leite, Miguel Srougi
Format:	Article
Language:	English
Published:	Faculdade de Medicina / USP 2008-01-01
Series:	Clinics
Subjects:	Prostate Cancer Tumor Volume Prognosis Prostate Specific Antigen Radical Prostatectomy
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000600009

Similar Items

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Significance of the correlation between serum-prostate specific antigen and the percentage of prostate cancer volume in postoperative biochemical progression
by: Spasić Aleksandar, et al.
Published: (2017-01-01)

Prognostic significance of a novel indicator (PSApostd3/PSApre) for PSA recurrence in patients after radical prostatectomy
by: Zhou Z, et al.
Published: (2019-06-01)

Prostate-specific antigen 10–20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6
by: Glen Denmer R. Santok, et al.
Published: (2017-03-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

O padrão 4 de Gleason e o volume tumoral no prognóstico do carcinoma da próstata Well differentiated localized prostate carcinoma: prognostic relevance of tertiary Gleason pattern 4 and tumor volume
by: Katia R. M. Leite, et al.
Published: (2005-12-01)

THE CORRELATION BETWEEN SERUM PSA LEVEL AND PROSTATE HISTOLOGIC AGGRESSIVENESS WITH PROSTATIC VOLUME IN BPH PATIENTS
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2019-01-01)

Robotic perineal radical prostatectomy with high prostate volume
by: Volkan Tugcu, et al.
Published: (2018-03-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Association of Connexin 32 with Prostate Volume and PSA Level in Prostatic Adenocarcinoma and Adenomyomatous Hyperplasia
by: Havva Erdem, et al.
Published: (2020-06-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
by: Yu-Cheng Lu, et al.
Published: (2021-01-01)

Analysis of prostate cancer in Tamil Nadu and Pondicherry: Are we missing the boat?
by: A Mukherjee, et al.
Published: (2006-01-01)

Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin
by: Yong Jin Kang, et al.
Published: (2017-05-01)

Association between PSA values and surveillance quality after prostate cancer surgery
by: Christina Hunter Chapman, et al.
Published: (2019-12-01)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
by: Jin-Woo Jung, et al.
Published: (2019-01-01)

Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
by: Yi-Shuo Wu, et al.
Published: (2018-01-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

THE CORRELATIONS AMONG COMPONENTS OF METABOLIC SYNDROME PSA AND PROSTATE VOLUME IN BPH PATIENTS
by: Yanuar Wicaksana Sumasta, et al.
Published: (2016-09-01)

EFEK KATETER TERHADAP FUNGSI PSA SERUM SEBAGAI PREDIKTOR VOLUME PROSTAT PADA PASIEN YANG TERBUKTI BENIGN PROSTATIC HYPERPLASIA PADA PEMERIKSAAN HISTOPATOLOGIS
by: Untung Tranggono, et al.
Published: (2014-09-01)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
by: Philipp Mandel, et al.
Published: (2021-07-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)

Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
by: Aradhana M. Venkatesan, et al.
Published: (2021-01-01)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
by: Freddie C Hamdy, et al.
Published: (2020-08-01)

Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
by: Р. V. Bulychkin, et al.
Published: (2019-07-01)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
by: Jure Murgic, et al.
Published: (2021-05-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

Biochemical recurrence after radical prostatectomy: what does it mean?
by: Rafael Tourinho-Barbosa, et al.

Prostatic Leiomyoma: A Case Report
by: Annelies Ringoir, et al.
Published: (2016-11-01)

Yüksek Riskli Prostat Kanserinde Radikal Prostatektomi
by: Taha Numan Yıkılmaz, et al.
Published: (2016-09-01)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
by: Priya Duvedi, et al.
Published: (2019-05-01)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

Impact of positive surgical margin on biochemical recurrence following radical prostatectomy in locally advanced prostate cancer
by: Cavit Ceylan, et al.
Published: (2016-10-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups
by: Wen Deng, et al.
Published: (2021-09-01)

Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis
by: Yu Zheng, et al.
Published: (2020-09-01)

Abdominal or Transrectal Ultrasonographic Prostate Volume and Cystoscopic Prostatic Urethral Length Measurements to Determine the Surgical Technique for Prostatectomy in Patients with Benign Prostate Hyperplasia
by: Aslan Demir, et al.
Published: (2016-12-01)

Cannot write session to /tmp/vufind_sessions/sess_5agk2dl3bk67gp9e6jmne12qrp